retatrutide triple agonist glp-1 gip glucagon phase 3 2025 Dual and Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports Triple G Agonists – Retatrutide.

The systems that matter most for dementia prevention In longevity medicine, the practical question is not whether one therapy is good for the brain. The better question is whether the persons overall biology is moving toward resilience or vulnerability

Patients on GLP-1 medications should hold daily doses on the day of the procedure and weekly doses seven days prior to surgery

As one report notes, GLP-1 peptide manufacturing anchors the first amino acid to [polystyrene] beads and relies on coupling reagents and solvents that challenge green chemistry goals ( [20] )

Diabetes (Type 2) Available in NZ = Dulaglutide (Trulicity, weekly injection) or Liraglutide (Victoza, daily injection)

DPP IV inhibitor blocks mescaline-induced scratching and amphetamine-induced hyperactivity in mice